NovoCure Ltd. (NVCR)
17.82
-0.17
(-0.94%)
USD |
NASDAQ |
Aug 28, 16:00
17.66
-0.16
(-0.90%)
After-Hours: 20:00
NovoCure Cash from Operations (Quarterly) : 8.132M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.132M |
| March 31, 2026 | -13.52M |
| December 31, 2025 | -18.00M |
| September 30, 2025 | 20.57M |
| June 30, 2025 | -15.94M |
| March 31, 2025 | -35.66M |
| December 31, 2024 | -3.451M |
| September 30, 2024 | 10.38M |
| June 30, 2024 | -1.72M |
| March 31, 2024 | -31.57M |
| December 31, 2023 | -14.56M |
| September 30, 2023 | -19.31M |
| June 30, 2023 | -22.74M |
| March 31, 2023 | -16.73M |
| December 31, 2022 | -3.707M |
| September 30, 2022 | 22.42M |
| June 30, 2022 | 15.76M |
| March 31, 2022 | -3.687M |
| December 31, 2021 | 14.40M |
| September 30, 2021 | 24.40M |
| June 30, 2021 | 26.17M |
| March 31, 2021 | 17.78M |
| December 31, 2020 | 53.48M |
| September 30, 2020 | 30.97M |
| June 30, 2020 | 12.74M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.957M |
| December 31, 2019 | 6.962M |
| September 30, 2019 | 14.91M |
| June 30, 2019 | 9.066M |
| March 31, 2019 | -4.315M |
| December 31, 2018 | 16.81M |
| September 30, 2018 | 5.638M |
| June 30, 2018 | -7.493M |
| March 31, 2018 | -16.82M |
| December 31, 2017 | -2.898M |
| September 30, 2017 | 2.548M |
| June 30, 2017 | -5.876M |
| March 31, 2017 | -26.91M |
| December 31, 2016 | -13.72M |
| September 30, 2016 | -33.50M |
| June 30, 2016 | -29.39M |
| March 31, 2016 | -30.98M |
| December 31, 2015 | -26.12M |
| September 30, 2015 | -22.11M |
| June 30, 2015 | -23.19M |
| March 31, 2015 | -28.47M |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | -18.65M |
| March 31, 2014 | -19.98M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| LivaNova Plc | 66.59M |
| EKF Diagnostics Holdings Plc | -- |
| Niox Group Plc | -- |
| Polarean Imaging Plc | -- |
| Accuray, Inc. | 2.427M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -6.378M |
| Cash from Financing (Quarterly) | 4.548M |
| Free Cash Flow | -25.43M |
| Free Cash Flow Per Share (Quarterly) | 0.0105 |
| Free Cash Flow to Equity (Quarterly) | 2.736M |
| Free Cash Flow to Firm (Quarterly) | 3.593M |
| Free Cash Flow Yield | -1.26% |